Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

Multiple Cancer Types

This clinical trial will evaluate DS-6000a in participants with advanced renal cell carcinoma (RCC) and ovarian cancer (OVC). The main goals of this study will be to investigate the recommended dose of DS-6000a that can be given safely to participants, assess the side effects of DS-6000a, and evaluate the effectiveness of DS-6000a.
Kidney (Renal Cell), Ovarian, Phase I
Rini, Brian

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: